HomeHealthcare and Life Sciences North America Advanced Therapy Medicinal Products Market

North America Advanced Therapy Medicinal Products Market Size, Share, Growth, and Industry Analysis, Type (Gene Therapy, Cell Therapy, Tissue Engineered Products), Application (Oncology, Cardiovascular Diseases, Rare Diseases), Regional Insights and Forecast to 2034

Report Code: SMI1805PUB | Last Updated : 16 July, 2026 | Base Year : 2025 | Historical Data : 2022-2024 | Region : North America | Format : PDF, Excel | Number of Pages : 140 | Author : Jenny Burkett

Table of Contents

  1. Executive Summary
    1. Introduction
  2. Market Introduction
    1. Market Definition
    2. Scope of the Study
    3. Market Structure
  3. Research Methodology
    1. Primary Research
    2. Research Methodology
    3. Assumptions & Exclusions
    4. Secondary Data Sources
  4. Market Factor Analysis
    1. Value Chain Analysis: North America Advanced Therapy Medicinal Products Market
    2. Porters Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitution
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Dynamics
    1. Drivers
    2. Restraints
    3. Opportunities
  6. Recent Trends Analysis
  7. Impact of COVID-19 on North America Advanced Therapy Medicinal Products Market
    1. Pre and Post Covid -19 Market Scenario Analysis
    2. Market Recovery Timeline and Challenge
    3. Measures Taken by Top Players
  8. Regulatory Landscape
  9. North America Advanced Therapy Medicinal Products Market , Type
    1. Introduction
      1. Market Size and Forecast, Type
    2. Gene Therapy
      1. Market Size and Forecast, By Region
    3. Cell Therapy
      1. Market Size and Forecast, By Region
    4. Tissue Engineered Products
      1. Market Size and Forecast, By Region
  10. North America Advanced Therapy Medicinal Products Market , Application
    1. Introduction
      1. Market Size and Forecast, Application
    2. Oncology
      1. Market Size and Forecast, By Region
    3. Cardiovascular Diseases
      1. Market Size and Forecast, By Region
    4. Rare Diseases
      1. Market Size and Forecast, By Region
  11. Regional Overview
    1. Introduction
      1. Market Size and Forecast
    2. North America
      1. Market Size and Forecast
        1. Type
          1. Gene Therapy
            1. Cell Therapy
              1. Tissue Engineered Products
              2. Application
                1. Oncology
                  1. Cardiovascular Diseases
                    1. Rare Diseases
                  2. U.S.
                    1. Type
                      1. Gene Therapy
                        1. Cell Therapy
                          1. Tissue Engineered Products
                          2. Application
                            1. Oncology
                              1. Cardiovascular Diseases
                                1. Rare Diseases
                              2. Canada
                          3. Competitive Landscape, 2025
                            1. Introduction
                            2. North America Advanced Therapy Medicinal Products Market Share Analysis, 2025 (%)
                              1. Market Share Analysis, 2025
                              2. Competition Ranking, 2025
                              3. Key Developments & Growth Strategies
                                1. Merger & Acquisition
                                2. Product Launch
                                3. Expansion
                              4. Consolidated SWOT Analysis of Key Players
                          4. Company Profile
                            1. Novartis AG
                              1. Business Overview
                              2. Financial Data
                              3. Key Product domains
                              4. Recent Developments
                            2. Gilead Sciences Inc.
                            3. Bristol Myers Squibb
                            4. Bluebird Bio
                            5. Spark Therapeutics
                            6. CRISPR Therapeutics
                            7. Editas Medicine
                            8. Sangamo Therapeutics
                            9. Takeda Pharmaceutical Company
                            10. Fate Therapeutics
                            11. Vertex Pharmaceuticals
                            12. BioNTech SE